acevaltrate has been researched along with Glioblastoma in 1 studies
*Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, BY; Jiang, SY; Kong, Y; Mao, XL; Sethi, G; Sun, T; Xu, YJ; Xu, Z; Zeng, YY | 1 |
1 other study(ies) available for acevaltrate and Glioblastoma
| Article | Year |
|---|---|
Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Glioblastoma; HEK293 Cells; Humans; Iridoids; Ubiquitin Thiolesterase; Ubiquitination | 2021 |